MTOR and prostate carcinoma: Androgen receptor signaling was reported to promote the PPP through mTOR-mediated upregulation of G6PD in human prostate cancer cell lines, and G6PD expression was closely correlated with prostate cancer progression using two animal models of Pten deletion/elevated mTOR pathway [54].